Apellis Pharmaceuticals News

Apellis Pharmaceuticals | DEF 14A: Definitive information statements

Apr 26 16:35 ET

Apellis Pharmaceuticals | DEFA14A: Others

Apr 26 16:18 ET

Apellis Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Feb 27 07:40 ET

Apellis Pharmaceuticals | 8-K: Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 27 07:35 ET

Apellis Pharmaceuticals | 8-K: Current report

Jan 22 00:00 ET

Apellis Pharmaceuticals | 8-K: Current report

Jan 8 00:00 ET

Apellis Pharmaceuticals | 8-K: Current report

Dec 14, 2023 07:04 ET

Apellis Pharmaceuticals | 8-K: Current report

Dec 1, 2023 08:37 ET

Apellis Pharmaceuticals | 8-K: Current report

Nov 1, 2023 07:59 ET

Apellis Pharmaceuticals | 8-K: Current report

Oct 5, 2023 07:15 ET

Apellis Pharmaceuticals | 8-K: Current report

Aug 29, 2023 07:05 ET

Apellis Pharmaceuticals | 8-K: Current report

Aug 22, 2023 16:49 ET

Apellis Pharmaceuticals | 8-K: Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

Jul 31, 2023 08:03 ET

Apellis Pharmaceuticals | 8-K: Current report

Jul 17, 2023 16:14 ET

Apellis Pharmaceuticals | 8-K: Current report

Jun 1, 2023 16:10 ET

Apellis Pharmaceuticals | DEFA14A: Others

Apr 21, 2023 09:03 ET

Apellis Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 21, 2023 09:00 ET

Apellis Pharmaceuticals | 8-K: Current report

Mar 15, 2023 16:37 ET

Apellis Pharmaceuticals | 8-K: Current report

Feb 24, 2023 09:27 ET

Apellis Pharmaceuticals | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers

Feb 22, 2023 07:17 ET